Literature DB >> 11713934

Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.

V Nehra1, P Angulo, A L Buchman, K D Lindor.   

Abstract

The aim of this study was to determine if a relationship exists between nonalcoholic steatohepatitis (NASH) and serum levels of free fatty acids, choline deficiency, or celiac disease. Forty-seven patients with liver biopsy proven NASH were enrolled. Total serum free fatty acids and anti-endomysial antibodies were determined in all patients, while plasma free and phospholipid-bound choline were determined in 29 patients. Total serum free fatty acid concentration correlated significantly with female gender and serum albumin concentration. Patients with severe fibrosis on liver biopsy had significantly greater serum concentration of free fatty acids than patients without severe fibrosis. Plasma free and phospholipid-bound choline levels were normal and no significant correlation was found between the concentration of plasma free or phospholipid bound choline, and the severity of liver damage. Only one of the 47 patients with NASH had a positive titer for the anti-endomysial antibody. In conclusion, increased serum concentrations of free fatty acids were found in NASH and were associated with development of more severe liver disease. Neither choline deficiency nor celiac sprue by anti-endomysial antibody testing was associated with NASH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713934     DOI: 10.1023/a:1012338828418

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  The liver in obesity.

Authors:  S ZELMAN
Journal:  AMA Arch Intern Med       Date:  1952-08

2.  Plasma choline concentration in humans fed parenterally.

Authors:  N F Sheard; J A Tayek; B R Bistrian; G L Blackburn; S H Zeisel
Journal:  Am J Clin Nutr       Date:  1986-02       Impact factor: 7.045

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 4.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

Review 5.  Dietary choline: biochemistry, physiology, and pharmacology.

Authors:  S H Zeisel
Journal:  Annu Rev Nutr       Date:  1981       Impact factor: 11.848

6.  Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients.

Authors:  A L Buchman; M Dubin; D Jenden; A Moukarzel; M H Roch; K Rice; J Gornbein; M E Ament; C D Eckhert
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

7.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

8.  Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis?

Authors:  P Bedossa; K Houglum; C Trautwein; A Holstege; M Chojkier
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

9.  Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy.

Authors:  P Vajro; A Fontanella; M Mayer; A De Vincenzo; L M Terracciano; M D'Armiento; R Vecchione
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

10.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

View more
  69 in total

1.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

Authors:  Lei Shen; Jian-Gao Fan; Yan Shao; Min-De Zeng; Jun-Rong Wang; Guo-Hao Luo; Ji-Qiang Li; Si-Yao Chen
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA.

Authors:  Sophie C Cazanave; Justin L Mott; Nafisa A Elmi; Steven F Bronk; Howard C Masuoka; Michael R Charlton; Gregory J Gores
Journal:  J Lipid Res       Date:  2011-06-01       Impact factor: 5.922

Review 3.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 4.  Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Metin Basaranoglu; Serra Kayacetin; Nevin Yilmaz; Ertugrul Kayacetin; Orhan Tarcin; Abdullah Sonsuz
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 5.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

Review 6.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

7.  Dietary composition and nonalcoholic fatty liver disease.

Authors:  Steven Solga; Amir R Alkhuraishe; Jeanne M Clark; Mike Torbenson; Ashli Greenwald; Anna Mae Diehl; Thomas Magnuson
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.

Authors:  Harmeet Malhi; Fernando J Barreyro; Hajime Isomoto; Steven F Bronk; Gregory J Gores
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

Review 9.  Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

10.  Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells.

Authors:  Yuren Wei; Dong Wang; Christopher L Gentile; Michael J Pagliassotti
Journal:  Mol Cell Biochem       Date:  2009-05-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.